ChemicalBook > CAS DataBase List >  ALC-0315

ALC-0315

Product Name
ALC-0315
CAS No.
2036272-55-4
Chemical Name
ALC-0315
Synonyms
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate);Lipid ALC-0315;6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate;ALC-0315(DHA);ALC0315,ALC 0315;Decanoic acid, 2-hexyl-, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester;((4-hydroxybutyl) azanediyl) bis (hexane-6,1-diyl) bis (2-hexyldecanoate)(ALC-0315);6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium;Decanoic acid, 2-hexyl-, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester ISO 9001:2015 REACH
CBNumber
CB78332786
Molecular Formula
C48H95NO5
Formula Weight
766.27
MOL File
2036272-55-4.mol
More
Less

ALC-0315 Property

Boiling point:
760.6±55.0 °C(Predicted)
Density 
0.919±0.06 g/cm3(Predicted)
solubility 
Soluble in Ethanol, DMSO, DMF
pka
15.11±0.10(Predicted)
form 
Liquid
color 
Colorless to light yellow
InChIKey
QGWBEETXHOVFQS-UHFFFAOYSA-N
SMILES
N(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)(CCCCCCOC(=O)C(CCCCCC)CCCCCCCC)CCCCO
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H225Highly Flammable liquid and vapour

H315Causes skin irritation

H319Causes serious eye irritation

Precautionary statements

P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

P233Keep container tightly closed.

P240Ground/bond container and receiving equipment.

P241Use explosion-proof electrical/ventilating/lighting/…/equipment.

P242Use only non-sparking tools.

P243Take precautionary measures against static discharge.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P303+P361+P353IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P337+P313IF eye irritation persists: Get medical advice/attention.

P370+P378In case of fire: Use … for extinction.

P403+P235Store in a well-ventilated place. Keep cool.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

BroadPharm
Product number
BP-25498
Product name
((4-hydroxybutyl)azanediyl)di(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purity
98%
Packaging
50mg
Price
$390
Updated
2021/12/16
BroadPharm
Product number
BP-25498
Product name
((4-hydroxybutyl)azanediyl)di(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purity
98%
Packaging
100mg
Price
$680
Updated
2021/12/16
BroadPharm
Product number
BP-25498
Product name
((4-hydroxybutyl)azanediyl)di(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purity
98%
Packaging
250mg
Price
$1100
Updated
2021/12/16
BroadPharm
Product number
BP-25498
Product name
((4-hydroxybutyl)azanediyl)di(hexane-6,1-diyl)bis(2-hexyldecanoate)
Purity
98%
Packaging
1g
Price
$2500
Updated
2021/12/16
DC Chemicals
Product number
DC42537
Product name
ALC-0315
Purity
>98%
Packaging
1g
Price
$2000
Updated
2021/12/16
More
Less

ALC-0315 Chemical Properties,Usage,Production

Description

ALC-0315 ([(4-hydroxybutyl)azanediyl]di(hexane-6,1-diyl) bis(2-hexyldecanoate)) is a synthetic lipid. A colorless oily material, it has attracted attention as a component of the SARS-CoV-2 vaccine, BNT162b2, from BioNTech and Pfizer. Specifically, it is one of four components that form lipid nanoparticles (LNPs), which encapsulate and protect the otherwise fragile mRNA that is the active ingredient in these drugs. These nanoparticles promote the uptake of therapeutically effective nucleic acids such as oligonucleotides or mRNA both in vitro and in vivo.

Uses

ALC-0315 is one of the components of the BNT162b2 vaccine (0.43 mg per dose). Its chemical properties as a tertiary amine mean that its cation can form an ionic bond to the messenger RNA which carries the genetic information for the SARS-CoV-2 spike protein formation in the human body. Importantly, once the lipid nanoparticle which encapsulates the mRNA has been absorbed into antigen-presenting cells (a process called receptor-mediated endocytosis) the more acidic environment within the endosome fully protonates the ALC-0315 as a result the nanoparticle releases its payload of mRNA.

Application

ALC-0315 is a cationic lipid and is critical to the self-assembly process of the particle itself, the ability of the particle to be taken up into cells and the escape of the RNA from the endosome.
ALC-0315 is the functional cationic lipid component of the drug product. When incorporated in lipid nanoparticles, it helps regulate the endosomal release of the RNA. During drug product manufacturing, introduction of an aqueous RNA solution to an ethanolic lipid mixture containing ALC-0315 at a specific pH leads to an electrostatic interaction between the negatively charged RNA backbone and the positively charged cationic lipid. This electrostatic interaction leads to encapsulation of RNA drug substance resulting with particle formation. Once the lipid nanoparticle is taken up by the cell, the low pH of the endosome renders the LNP fusogenic and allows the release of the RNA into the cytosol.

Biological Functions

Main ingredient in the lipid-nanoparticle that delivers the mRNA into the cell.
Cationic (positively charged) lipid that during the manufacturing process, promotes the nanoparticle to assemble into a virus size particle with the negatively charged mRNA in the middle, and facilitates mRNA release from the nanoparticle once inside the cell.

Biological Activity

ALC-0315 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles. Administration of severe acute respiratory coronavirus 2 (SARS-CoV-2) mRNA in ALC-0315-containing lipid nanoparticles induces the production of IgG that binds to the SARS-CoV-2 receptor-binding domain (RBD) in rhesus macaques, with a boost in antigen-specific IgG geometric mean titers (GMT) seven and 14 days after a second dose. Formulations containing ALC-0315 have been used in the development of lipid nanoparticles for the delivery of mRNA-based vaccines.

Side effects

The most common adverse reaction to SARS-CoV-2 mRNA vaccine containing ALC-0315 (generated by Pfizer-BioNTech ) was anaphylaxis, with some patients experiencing systemic allergic reactions. The allergens of the LNP-based COVID-19 vaccine may be related to LNP (and/or vesicle) aggregates, and whether these aggregates can trigger allergic reactions remains to be evaluated.

Synthesis

The preparation of ALC-0315 was first described in a patent application to lipid nanoparticles by Acuitas Therapeutics in 2017.? The final step is a reductive amination reaction in which 4-aminobutanol is condensed with a lipid aldehyde, using sodium triacetoxyborohydride as the reducing agent to convert the intermediate imines to the amine of the product.

References

1. Vogel, A.B., Kanevsky, I., Che, Y., et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592(7853), 283-289 (2021).

ALC-0315 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

ALC-0315 Suppliers

Xiamen Sinopeg Biotech Co., Ltd.
Tel
400-400-9189898
Email
sales@sinopeg.com
Country
China
ProdList
305
Advantage
58
Shochem(Shanghai)Co.,Ltd
Tel
+86-021-51783479 +86-13816874662
Fax
021-50800795
Email
info@shochem.com
Country
China
ProdList
311
Advantage
58
AVT(Shanghai) Pharmaceutical Tech Co., Ltd.
Tel
021-58876118 15692161719
Email
avt013@avt-cn.com
Country
China
ProdList
93
Advantage
58
Heze Development Zone chuangli Chemical Co., Ltd.
Tel
+86-530-529 6766,+86-15666160102 15666160102
Fax
0530-529 6766
Email
info@chuangli-chem.com
Country
China
ProdList
896
Advantage
55
Shochem (Shanghai) Co.,Ltd
Tel
13611745246 13816874662
Email
sales@shochem.com
Country
China
ProdList
541
Advantage
58
Pharmalego
Tel
13472578225 18321033991
Email
marketing@pharmalego.com
Country
China
ProdList
2961
Advantage
58
Asymchem Labs.
Tel
17347534561
Email
liujingjing0710@asymchem.com.cn
Country
China
ProdList
435
Advantage
58
Beijing Ouhe Technology Co., Ltd
Tel
010-82967028 13552068683
Fax
+86-10-82967029
Email
2355560935@qq.com
Country
China
ProdList
12390
Advantage
60
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 17702719238
Email
sales@sun-shinechem.com
Country
China
ProdList
985
Advantage
64
Tianjin Derchemist Science & Technology Co., Ltd.
Tel
22-58627059 13920586291
Fax
022-58620305
Email
zdcomcon@126.com
Country
China
ProdList
3461
Advantage
50
More
Less

View Lastest Price from ALC-0315 manufacturers

XIAMEN SINOPEG BIOTECH CO., LTD.
Product
ALC-0315(DHA) 2036272-55-4
Price
US $0.00-0.00/g
Min. Order
1g
Purity
98%
Supply Ability
1g/bottle , 10g/bottle, 100g/bottle
Release date
2024-11-25

2036272-55-4, ALC-0315Related Search:


  • Decanoic acid, 2-hexyl-, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester
  • ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
  • Decanoic acid, 2-hexyl-, 1,1'-[[(4-hydroxybutyl)imino]di-6,1-hexanediyl] ester ISO 9001:2015 REACH
  • 6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate
  • Lipid ALC-0315
  • ((4-hydroxybutyl) azanediyl) bis (hexane-6,1-diyl) bis (2-hexyldecanoate)(ALC-0315)
  • ALC0315,ALC 0315
  • 6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium
  • ALC-0315(DHA)
  • 2036272-55-4
  • 203672-55-4
  • C48H95NO5